digital currency replace cash, Block

This year, the amount of M&A transactions involving listed companies in Hong Kong has reached 38 billion US dollars, which has triggered a rare bidding war. This year is expected to be the busiest year for M&A transactions involving listed companies in Hong Kong in the past decade, with industries ranging from skin care products to logistics real estate, and the bidding war has also warmed up. It is reported that China Mobile's bid for Hongkong Broadband may face competition from American private equity firm I Squared Capital. Bi Hua, chairman of Fenmei Packaging, is negotiating with Qihao Capital to jointly counter the privatization offer of Shandong Xinjufeng. The data shows that the scale of M&A transactions for listed companies in Hong Kong has reached $38 billion this year, the highest level since 2017, including the merger of Guotai Junan Securities and Haitong Securities, a smaller competitor, to become the largest brokerage firm in China.The USD/JPY rose more than 30 points against the Japanese yen in the short term and is now reported at 152.56.China galaxy International lowered the target price of Yanghe shares from RMB 88.00 to RMB 84.00.

Korean Air passed the US antitrust review, clearing the way for completing the Asiana Airlines transaction.Daiwa Capital Market raised the target price of Tesla from $285 to $420.Pakistan KSE-100 Index rose 2% to 113,268.80.

Citigroup slightly lowered South Korea's GDP growth forecast to 1.5% next year. It is expected that the Bank of Korea will cut interest rates next month. Citigroup released a report saying that considering the worse economic sentiment in South Korea this month, it slightly lowered its GDP forecast for this year and next year by 0.1 percentage point to 2.1% and 1.5% respectively. The bank slightly lowered Korea's GDP growth forecast for the last quarter of this year by 0.1 percentage point to rise by 0.3% quarterly, and raised its GDP growth forecast for the first quarter of next year by 0.1 percentage point to rise by 0.6% quarterly. Looking forward to the first quarter of next year, the bank expects South Korea to adopt a combination of expansionary policies, including the Bank of Korea's expected interest rate cut to 2.75% in mid-January, and the government's expected additional budget of 30 trillion won (equivalent to about 1.1% of GDP next year). It is expected that the Bank of Korea will cut interest rates by 25BP each in January, April, July and October next year, and the final interest rate is expected to be 2%.Sources: The Bank of Japan tends to keep interest rates unchanged next week. Five sources familiar with the Bank of Japan's thinking said that the Bank of Japan tends to keep interest rates unchanged next week because policymakers tend to spend more time examining overseas risks and clues about salary increase next year. Any similar decision will increase the possibility that the Bank of Japan will raise interest rates at its meeting in January or March next year, when there will be more information about the wage increase next year. The source also said that there was no consensus within the Bank of Japan on the final decision, and some people in the Committee still believed that Japan had met the conditions for raising interest rates in December. This decision will depend on each member's belief in the possibility of achieving wage-driven sustained price increases in Japan. If upcoming events, such as next week's meeting of the Federal Reserve, trigger another sharp fall in the yen, thus intensifying inflationary pressure, the Bank of Japan may also agree to raise interest rates. But overall, many BoJ policymakers seem to be in no hurry to pull the trigger.The tenth batch of centralized procurement of drugs organized by the state will be opened in Shanghai today (12th), and the bid will be selected. It is understood that this collection involves a total of 62 drugs and 263 product specifications, which is the highest in all previous collections. Covers a variety of therapeutic fields such as hypertension, diabetes, tumor, cardiovascular and cerebrovascular diseases, infection, mental illness, and electrolyte supplementation. (CCTV Finance)